Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-222-2 | CAS number: 1115-20-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
IN VITRO
In the Ames Test for hydroxy pivalic acid neopentylglycol ester (HPN; 1115-20-4; BASF, 2023; OECD 471) S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E.coli WP2 uvrA were exposed with and without metabolic activation to dose levels of 0 (vehicle control), 33-5000 µg/plate. The positive and negative controls were valid. No precipitation of the test substance was observed with and without S9 mix. A bacteriotoxic effect was occassionally observed depending on the strain and test conditions at and above 2500 µg/plate. No increase in revertants was found at any dose level in any strain studied. Conclusion: No mutagenic effects with and without metabolic activation at dose levels up to 5000 µg/plate.
In a former Ames Test (BASF, 1979, guideline 471 study with some restrictions) S. typhimurium TA 1535, TA 1537, TA 1538, TA 98, TA 100 were exposed with and without metabolic activation to dose levels of 0 (vehicle control), 4, 20, 100, 500, 2500 µg/plate. The positive and negative controls were valid. No cytotoxic effects were detected at these dose levels. No increase in revertants was found at any dose level in any strain studied. Conclusion: No mutagenic and no cytotoxic effects with and without metabolic activation at dose levels up to 2500 µg/plate.
In the GLP OECD 476 study (BASF SE, 2010), hydroxypivalic acid neopentylglycol ester flakes (HPN) were tested in the in vitro mamalian cell gene mutation test. CHO cells were treated with up to 2100 µg/ml for 4 and 24 h with and without S9 mix. HPN did not lead to a relevant increase in the number of mutant colonies either with or without metabolic activation in 2 independent experiments. The mutant frequencies at any concentration were close to the range of the concurrent negative control values and clearly within the range of our historical negative control data. No cytotoxicity was observed. Vehicle and positive controls were valid. Therefore, HPN flakes is concluded to be not a mutagenic substances in the HPRT locus assay.
The GLP OECD 473 study (BASF SE, 2010) hydroxypivalic acid neopentylglycol ester (HPN) was assessed for its potential to induce structural chromosomal aberrations (clastogenic activity) and/or changes in the number of chromosomes (aneugenic activity) in vitro +/- metabolic activation. V79 cells were exposed with up to 2050 µg/ml (about 10 mM) for 4 h +/- S9 mix and 18 h sampling time. Negative and positive controls were valid. A slight increase of aberrant metaphase cells observed in the 1st experiment +S9 mix This result was not confirmed in the 2nd experiment. No increase in the frequency of cells containing numerical chromosome aberrations was demonstrated either. HPN, however, caused a statistically significant and biologically relevant increase in the number of structurally aberrant metaphases -S9 mix >= 1367 µg/ml.
This positive result is unexpected; one explanation on this in vitro result may be, that HPN was cleaved intracellularly to hydroxy pivalic acid and NPG. Intracellular cleavage resulting in an intracellular pH shift may have caused the effect. This mechanism is expected not to be relevant in the in vivo situation, as shown with the negative in vivo MNT test.
IN VIVO
This study was performed to investigate the potential of HPN (1115 -20 -4)to induce micronuclei in polychromatic erythrocytes (PCE) in the bone marrow of the mouse according to OECD 474 guideline and GLP (Harlan CCR, 2013).
Seven males per test group (except the vehicle and positive control groups with 5 males only) were evaluated for the occurrence of micronuclei. Per animal 2000 polychromatic erythrocytes (PCEs) were scored for micronuclei. To investigate a cytotoxic effect due to the treatment with the test item the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and reported as the number of PCEs per 2000 erythrocytes. The following dose levels of the test item were investigated, based on results of a preexperiment:
24 h preparation interval: 500, 1000, and 2000 mg/kg b.w. and 48 h preparation interval: 2000 mg/kg b.w.
After treatment with the test item several animals showed transient clinical signs such as abdominal position, eyelid closure and/or ruffled fur.
After treatment with the test item the number of PCEs per 2000 erythrocytes was not substantially decreased as compared to the mean value of PCEs per 2000 erythrocytes of the vehicle control thus indicating that Hydroxypivalic acid neopentylglycolester did not exert a cytotoxic effect in the bone marrow. In comparison to the corresponding vehicle controls there was no biologically relevant or statistically significant enhancement in the frequency of the detected micronuclei at any preparation interval after administration of the test item and with any dose level used.
In conclusion, it can be stated that under the experimental conditions reported, the test item Hydroxypivalic acid neopentylglycolester did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the mouse.
Justification for classification or non-classification
No classification and labelling concerning genetic toxicity is required according to Annex VI of Directive 67/548/EWG or Annex I of Directive 1272/2008 (EU-GHS) as labelling criteria are not met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.